Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrimidine SCHEMBL1846 | 1.00 | — | — | |
| Pyrimidine SCHEMBL19437633 | 1.00 | TSHR (0.50) | TSHRNAPRTTDP1CYP2A6ALDH1A1 | |
| Pyrimidine SCHEMBL606542 | 0.95 | — | — | |
| Pyrimidine SCHEMBL3987505 | 0.95 | — | — | |
| Pyrimidine SCHEMBL1054141 | 0.95 | — | — | |
| Pyrimidine SCHEMBL383109 | 0.95 | — | — | |
| Pyrimidine SCHEMBL9120472 | 0.95 | — | — | |
| Pyrimidine SCHEMBL21315895 | 0.95 | TSHR (0.46) | TSHRNAPRTTDP1CYP2A6ALDH1A1 | |
| Pyrimidine SCHEMBL22346941 | 0.95 | — | — | |
| Pyrimidine SCHEMBL9545353 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190003966-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | SENA RESEARCH, INCORPORATED (US) | 2019-01-03 | — | — | US | claimed |
| EP-2780303-A1 | SEPARATION TECHNIQUE, PHOTO-OXIDATION OF ORGANIC SUBSTRATES, AND PHOTO CATALYSTS | The University Of Nottingham (GB) | 2014-09-24 | — | — | EP | claimed |
| US-20130183765-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | Sena Research Incorporated (US) | 2013-07-18 | — | — | US | claimed |
| WO-2013072678-A1 | SEPARATION TECHNIQUE, PHOTO-OXIDATION OF ORGANIC SUBSTRATES, AND PHOTO CATALYSTS | THE UNIVERSITY OF NOTTINGHAM (GB) | 2013-05-23 | — | — | WO | claimed |
| WO-2013058767-A1 | MATERIALS AND METHODS TO DETECT PYRIMIDINE-PYRIMIDINE DIMER FORMATION | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-04-25 | — | — | WO | claimed |
| WO-2012037158-A2 | ULTRAVIOLET AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHODS FOR THE EVALUATION OF SUNSCREEN EFFICACY | SENA RESEARCH, INCORPORATED (US) | 2012-03-22 | — | — | WO | claimed |
| US-20090246853-A1 | DIRECTED EVOLUTION METHOD | MEDICAL RESEARCH COUNCIL (GB) | 2009-10-01 | — | — | US | claimed |
| EP-1806406-A2 | Directed evolution method | Medical Research Council (GB) | 2007-07-11 | — | — | EP | claimed |
| US-20050031638-A1 | Vaccine | SMITHKLINE BEECHAM BIOLOGICALS S.A. | 2005-02-10 | — | — | US | claimed |
| US-20040005594-A1 | Directed evolution method | MEDICAL RESEARCH COUNCIL | 2004-01-08 | — | — | US | claimed |
| EP-1317539-A2 | DIRECTED EVOLUTION METHOD | MEDICAL RESEARCH COUNCIL (GB) | 2003-06-11 | — | — | EP | claimed |
| WO-2002022869-A2 | DIRECTED EVOLUTION METHOD | MEDICAL RESEARCH COUNCIL (GB) | 2002-03-21 | — | — | WO | claimed |
| EP-1040123-A2 | HUMAN PAPILLOMAVIRUS VACCINE | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2000-10-04 | — | — | EP | claimed |
| WO-2000054803-A2 | IMMUNOSTIMULATORY NUCLEIC ACIDS AND ANTIGENS | PANACEA PHARMACEUTICALS, LLC (US) | 2000-09-21 | — | — | WO | claimed |
| WO-1999033868-A2 | HUMAN PAPILLOMAVIRUS VACCINE | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-07-08 | — | — | WO | claimed |
| US-20250367419-A1 | DRUG DELIVERY SYSTEM COMPRISING AN AGENT EFFECTIVE IN THE TREATMENT OR PREVENTION OF AN ESOPHAGEAL DISEASE FOR THE APPLICATION TO ESOPHAGEAL MUCOUS MEMBRANES | ESOCAP AG (CH) | 2025-12-04 | — | — | US | disclosed |
| EP-4536195-A1 | DRUG DELIVERY SYSTEM COMPRISING AN AGENT EFFECTIVE IN THE TREATMENT OR PREVENTION OF AN ESOPHAGEAL DISEASE FOR THE APPLICATION TO ESOPHAGEAL MUCOUS MEMBRANES | EsoCap AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| EP-0167238-A1 | Displacement polynucleotide assay method and polynucleotide complex reagent therefor | ALLIED CORPORATION (US) | 1986-01-08 | — | — | EP | disclosed |
| EP-0164876-A1 | Displacement polynucleotide assay employing recombination protein and diagnostic kit | ALLIED CORPORATION (US) | 1985-12-18 | — | — | EP | disclosed |
| US-4184271-A | Molecular model | BARNETT JAMES W JR | 1980-01-22 | — | — | US | disclosed |